TWIST BIOSCIENCE CORP (TWST)

Company Profile

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 919 full-time employees. The company went IPO on 2018-10-31. The firm's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The firm leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. The company has miniaturized traditional chemical DNA synthesis reactions to write over one million short pieces of DNA on each silicon chip. The company offers two product lines: synthetic biology tools and NGS tools, that address different needs of its customers across a variety of applications. The company offers ribonucleic acid and protein products. Its synthetic biology products include synthetic genes and gene fragments, and oligonucleotide or oligo pools.

Company Info

TWIST BIOSCIENCE CORP

681 Gateway Blvd.

South San Francisco CALIFORNIA 94080

P: 18007190671

CEO: Emily M. Leproust

Employees: 919

Website: https://www.twistbioscience.com/